Huda Salman MD
Hematologic Oncology
Associate Professor, Internal Medicine, Stony Brook University School of Medicine
Join to View Full Profile
Brown center Indiana UniversityIndianapolis, IN 46202
Dr. Salman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1999 - 2002
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1996 - 1999
University of Jordan Faculty of MedicineClass of 1991
Certifications & Licensure
IN State Medical License 2021 - 2025
NY State Medical License 2015 - 2022
GA State Medical License 2013 - 2016
VA State Medical License 2011 - 2014
OH State Medical License 2009 - 2012
MO State Medical License 2006 - 2010
TN State Medical License 2005 - 2007
American Board of Internal Medicine Hematology
Clinical Trials
- CD4CAR for CD4+ Leukemia and Lymphoma Start of enrollment: 2020 Jul 09
Roles: Study Chair, Contact, Sponsor-Investigator, Principal Investigator
- Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML. Start of enrollment: 2024 Feb 21
Roles: Principal Investigator, Sponsor-Investigator, Contact
- Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) As a Bridge to Allogeneic Stem Cell Transplant Start of enrollment: 2024 Mar 19
Roles: Principal Investigator, Sponsor-Investigator, Contact
Publications & Presentations
PubMed
- Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations.Mei Luo, Jingwen Yang, Alejandro A Schäffer, Chengxuan Chen, Yuan Liu
Cancer Discovery. 2025-03-03 - Engineering resilient CAR T cells for immunosuppressive environment.Malak Khalifeh, Huda Salman
Molecular Therapy. 2025-01-25 - 2 citationsNCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.John A Thompson, Bryan J Schneider, Julie Brahmer, Mohammad Abu Zaid, Amaka Achufusi
Journal of the National Comprehensive Cancer Network. 2024-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
